Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/CE

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/CE History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/CE(x) 1.572.651.973.003.43

What is the latest EV/CE ratio of NATCO PHARMA ?

The latest EV/CE ratio of NATCO PHARMA is 1.57 based on Mar2025 Consolidated results.
Year EV/CE
Mar20251.57
Mar20242.65
Mar20231.97
Mar20223.00
Mar20213.43

How is EV/CE of NATCO PHARMA Trending?

Years EV/CE % Change
Mar2025 1.57
-40.75
Mar2024 2.65
34.52
Mar2023 1.97
-34.33
Mar2022 3
-12.54
Mar2021 3.43 -

Other Financial Ratios of NATCO PHARMA


Compare EV/CE ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,491.5 Cr -3.1% 3% -11.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,711.0 Cr -0.8% 3.5% 14.7% Stock Analytics
DIVIS LABORATORIES ₹192,376.0 Cr -1% 7.3% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,655.0 Cr -0.9% 10.1% 44.6% Stock Analytics
CIPLA ₹113,979.0 Cr -2.1% -1.8% -6% Stock Analytics
DR REDDYS LABORATORIES ₹96,204.7 Cr -5.8% -13.2% -7.7% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-3.1%

3%

-11.1%

SENSEX

-2.7%

-0.2%

-8%


You may also like the below Video Courses